bv-cdiResearch Supported by FAPESP
The referential information source for Research Supported by FAPESP
University of Toronto
The agreement with the University of Toronto (UofT), Canada, aims at implementing scientific and technological cooperation between researchers from UofT and from the State of São Paulo, through the funding of joint research projects.
Recent advances have highlighted the advantages of using macrocyclic compounds as a basis for protein kinase inhibitors. However, the design and synthesis methodologies for such macrocyclic inhibitors are at an early stage. SGC-Unicamp works on inhibitor development for several protein kinases which are good candidates for development of macrocyclic inhibitors. Those candidate kinases can…
Antibodies are produced by the immune response to foreign antigens, however this response is limited to an individual's immune system, and for this reason, synthetic antibodies enable applications beyond the extent of natural antibodies. Recombinant antibodies can be obtained from synthetic antibody libraries through the use of several technologies, among them phage display technology (Zh…